Study Finds Women Who Take the Contraceptive Pill are Less Likely to Develop Serious Coronavirus

August 6, 2020 by Christen Aldrich

Filed under COVID-19 for Employers, COVID-19 for the Workforce

Last modified August 7, 2020

According to this new post by The Telegraph, a major new study has found women who take the pill are less likely to develop serious coronavirus, helping explain why men have suffered worse from the disease.

Analysis of more than half a million women by King’s College London during May and June has identified the crucial role of oestrogen in protecting against COVID-19. Scientists established that those taking the combined oral contraceptive pill were on average 13 percent less likely to develop serious symptoms.

Previous studies of other dangerous respiratory viruses, such as Sars and Mers, had suggested the importance of oestrogen. However, the new King’s research, conducted using data from their symptom tracking app, is the first of its kind to establish the link with COVID-19.

Oestrogen is thought to influence how many immune cells a person produces and how well these respond to infection. Known as the “female hormone,” it is present in higher proportions in women than in men.

Share this

Related Articles

                                Leave a Comment